The trademark application StabiKal was filed by CKD PHARM, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on April 25, 2023, and it was registered by office on August 2, 2023 without any oppositions.
The application was filed in French (English was selected as the second language).